On March 22, 2023, the U.S. Senate Committee on Homeland Security and Governmental Affairs released Short Supply: the Health and National Security Risks of Drug Shortages. The report noted that drug shortages peaked in 2022, and also that “[the shortages] are caused by a number of factors, including economic drivers, insufficient supply chain visibility, and a continued U.S. overreliance on both foreign and geographically concentrated sources for medications and their raw materials.” The report detailed six key findings of fact and offered six recommendations to address the issue. The report concluded that if the federal government and the pharmaceutical industry do not work together to address these issues, then drug shortages will persist and continue to pose health and national security risks.